Corn-Based Pharmaceutical Ingredients & Biochemicals Investment Proposal

Investment Opportunity: Corn-Based Pharmaceutical Ingredients & Biochemical Manufacturing in India

Business Overview

We are inviting foreign investors to partner in setting up a pharmaceutical and biochemical manufacturing unit using corn-derived ingredients in Chhattisgarh, India — a region rich in corn production. Corn starch, dextrose, and sorbitol are key ingredients in global pharmaceutical and biotech industries. We offer full local support and land for plant setup, with a flexible partnership model.

Why Corn-Based Ingredients?

• Corn starch is a widely used excipient in tablets and capsules.

• Dextrose and sorbitol are used in oral and IV formulations.

• Biochemicals like lactic acid and maltodextrin are in global demand.

• Suitable for pharma, nutraceuticals, medical research, and biotech industries.

• Demand for non-synthetic, plant-based inputs is growing rapidly worldwide.

• High-value export opportunities.

• Growing global demand for natural excipients and biochemicals

• India is a global pharma hub – 3rd largest exporter by volume

• Corn starch is a safe, biodegradable, non-toxic base for medicines

• High-margin industry with long-term demand

• Opportunity to serve domestic and export markets

• Used in tablets, capsules, glucose, syrups, and drug formulations

Products to Manufacture

• Pharmaceutical Grade Corn Starch

• Dextrose Monohydrate & Anhydrous

• Sorbitol (USP Grade)

• Liquid Glucose

• Maltodextrin

• Lactic Acid

• Xylitol

• Modified Starches

• Biochemical fermentation base (for vaccine, probiotic industries)

Applications

• Tablet binding & disintegration

• Glucose IV and oral electrolyte products

• Sweetening and carrier agents in syrups

• Fermentation for vaccine and antibiotic manufacturing

• Nutraceuticals, baby food, probiotics

Production Process

1. Corn starch extraction

2. Enzymatic hydrolysis

3. Fermentation (where required)

4. Filtration & drying

5. Purification and grading

6. Packaging (bulk or pharma packs)

Required Certifications

• WHO-GMP

• ISO 9001 / ISO 22000 / HACCP

• FDA (India and optionally US FDA)

• FSSAI (for nutrition-grade)

• REACH (for EU exports)

• Export registration (IEC + DGFT)

Market Scope

• Pharmaceutical manufacturers in India & abroad

• Export buyers in Europe, US, Japan

• Biotech companies

• Medical R&D labs and universities

• Nutraceutical brands

Business Potential

• High-profit margins

• Recession-proof and export-ready industry

• Scope for long-term contracts with pharma buyers

• ROI possible

• High-value, low-volume products = easy logistics

Why Chhattisgarh is Ideal for This Plant:

• Raw material available in abundance

• Tribal maize mills

• land and labor cost in Kondagaon region

• State support for clean-tech

• Access to ports

• Environmentally safe location – favorable for bio manufacturing

Our Offer to Investors

• Land provided for factory setup

• Photos/videos of available land

• Assistance in raw material procurement from farmers

• Local manpower and operational support

• legal setup assistance

• Full partnership model available

Investor’s Role & Benefits:

• Provide investment in machinery, processing system

• Technical know-how

• Branding and global sales through export routes

• profit margin (retail);(bulk export)

• Full JV or long-term lease agreement possible

Contact Us:

📍 Location: Kondagaon, Chhattisgarh, India

Let’s build a global corn-based pharma manufacturing brand from India!